The Leadership Team at Biosynth drives the company's strategic vision and operational excellence in the antibody and custom peptide synthesis markets. Comprising the CEO, SVP of Peptide and Biologics Operations, CFO, and Global Head of Financial Planning and Analysis, this team collaborates to set financial goals, enhance production capabilities, and ensure sustainable growth while fostering innovation and maintaining high-quality standards in service delivery.